Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Clarity time again…clear out the mud..or should I say FUD

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Apr 18, 2024 7:20pm

68 Views

Post# 35997026

RE:RE:RE:RE:Clarity time again…clear out the mud..or should I say FUD

Wow I did not know that looking at sedar was 100% irrelevant and they posted the same mistake on their website under their filings....It would be nice if they were consistent so as to not cause confusion with shareholders...

That would be similar to someone saying that Matt exercised 350,000 options which was simply a mistake but of course some might say that it is completely irrelevant even though it is not.

And I would simply bet you 10k that I am a shareholder if you really want to call me out but of course you would never pay up anyway so that would be a red herring.

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market